PEDRO NUNEZ FERRO: Open Payments
NPI 1396225256 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,376 in 118 payments from 28 companies in 2025. Trend: 2023 $456 · 2024 $2,119 · 2025 $2,376
Food & beverage: $2,291Education: $85
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 22 | $328 |
| AstraZeneca Pharmaceuticals LP | 12 | $256 |
| Amgen Inc. | 17 | $251 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $208 |
| Astellas Pharma US Inc | 3 | $153 |
| Novo Nordisk Inc | 9 | $139 |
| Corcept Therapeutics | 6 | $130 |
| GlaxoSmithKline, LLC. | 4 | $101 |
| Exact Sciences Corporation | 5 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
Products named: Kerendia, MOUNJARO, FARXIGA, OTEZLA, JARDIANCE, Korlym, The Cologuard Plus Collection Kit, GEMTESA.
Industry payments across FL — which companies pay providers there.
